Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer
PURPOSE: High interest in triple-negative breast cancers is not surprising as this category of patients benefits neither from hormonal therapies nor from anti HER2 treatments. Blockade of angiogenesis by metronomic chemotherapy as well as other antiangiogenics might improve outcomes in this group of...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Medknow Publications
2015-01-01
|
| Serija: | Hematology/Oncology and Stem Cell Therapy |
| Teme: | |
| Online pristup: | https://journals.lww.com/10.1016/j.hemonc.2014.11.003 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|